Advance Venture Partners has led a USD 50 million Series A funding round for Conceivable Life Sciences, a Mexico-based company specializing in automated IVF services.

Information on the Target

Conceivable Life Sciences is a pioneering company based in Mexico that specializes in providing automated in-vitro fertilization (IVF) services. This innovative firm is committed to enhancing the fertility journey for individuals and couples through advanced technology and a streamlined process, making the IVF experience more accessible and efficient.

By leveraging automation and cutting-edge methodologies, Conceivable Life Sciences aims to improve the success rates of IVF treatments and reduce the challenges often faced in the traditional procedures. This focus on technology positions the company as a leader in a crucial segment of healthcare, catering specifically to reproductive health.

Industry Overview in Mexico

The fertility services industry in Mexico has been experiencing significant growth over the past few years, driven by increasing awareness and acceptance of assisted reproductive te